Physician profile
Scott Walker Lisson
NPI 1396726394
$1,621.38
in general payments reported to CMS, 2019-2025
21 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $41.55 · 2021: $39.05 · 2022: $218 · 2023: $339 · 2024: $500 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $263.76 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $147.05 | 2019-2024 | Lumenis Pulse 50h, Moses 550 D\F\L |
| Antares Pharma, INC. | $136.80 | 2022 | |
| Medtronic, INC. | $133.74 | 2023-2025 | Altaviva, Interstim |
| Astellas Pharma US INC | $132.61 | 2019-2021 | |
| Calyxo, INC. | $129.53 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $122.07 | 2023 | |
| Urogen Pharma, INC. | $121.84 | 2024 | |
| Sumitomo Pharma America, INC. | $107.71 | 2023 | Gemtesa |
| Abbvie INC. | $67.11 | 2019-2023 | |
| Allergan, INC. | $44.51 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $35.23 | 2024 | Adstiladrin |
| Pfizer INC. | $32.68 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $31.46 | 2022 | |
| Olympus America INC. | $21.55 | 2023 | Itind System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $19.27 | 2025 | Bard Urinary Drainage Bag |
| Davol INC. | $17.32 | 2022 | |
| Sun Pharmaceutical Industries INC. | $16.58 | 2020 | |
| Verity Pharmaceuticals INC. | $14.79 | 2025 | Trelstar |
| Smith+Nephew, INC. | $13.80 | 2022 | |
| Rgh Enterprises LLC | $11.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Lisson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.